ArticleBiology of reproduction2026
Cetrorelix suppresses the dominant follicle and synchronizes follicular waves and ovulation in cattle†.
Article in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To determine the effects of a GnRH antagonist on ovarian function in cattle, we tested the hypotheses that cetrorelix will (1) cause regression of the extant dominant follicle by altering gonadotrophin secretion and (2) induce a new follicular wave emergence at a consistent time after treatment. In Experiment 1, heifers were given 1.5 mg cetrorelix im on Days 1-2 (Day 0 = wave emergence), Days 3-4, and Days 6-7, or normal saline (Control, n = 8 per group). The dominant follicle was smaller and regressed earlier in groups treated with cetrorelix on Days 1-2 or Days 3-4 than in Controls (P = 0.01). Plasma LH concentrations were lower (P = 0.04) for 3 days after treatment, and the pre-wave surge in FSH occurred earlier in groups treated with cetrorelix on Days 1-2 or Days 3-4 than Controls (P = 0.01). Corpus luteum diameter was smaller (P = 0.01) in the cetrorelix groups, but luteal vascularity, life-span, or progesterone production was not affected. In Experiment 2, heifers were treated with a single 3 mg dose of cetrorelix on Day 1, 3, or 6, or normal saline (Control, n = 8 per group), given prostaglandin F2a and inseminated. Wave emergence occurred synchronously 3.6 ± 0.3 days after cetrorelix treatment, ovulations occurred 12.4 ± 0.3 days later, and 13/23 heifers became pregnant. In Experiment 3, cetrorelix given at random days of the cycle induced a new wave 3.4 ± 0.3 days later and wave emergence was more synchronous than in saline-treated cows (Barlett test P = 0.04). Results supported hypotheses and provide rationale for the development of new cetrorelix-based protocols for breeding management in cattle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.